Transcript Dia 1 - FANC

Invoering en evolutie van
extremiteitendosimetrie in nucleaire
geneeskunde.
Van borst- naar vingerdosimetrie in een verloop van 30 jaar
Waarom voldoet borstdosimetrie niet?



2
Geconcentreerde bronnen
Hoge activiteiten
Bronisolatie
Nucg
16-7-2015
Situatie Nucg


3
Radiofarmacie: 2 fulltime equivalenten
Verpleging: 8 fulltime equivalenten
Nucg
16-7-2015
Kit preparation
Dispensing syringes
Administration
Eluting 99Mo-99mTc generator
in elution vial (50GBq)
Dispensing in syringes
from kit vial (800/400MBq)
Removing needle and
mounting syringe shield
Drawing small volume and
determining spec. activity
in dose calibrator
Checking activity in dose
calibrator
Possible adjustment
Drawing from elution vial
(typical: 18GBq)
Adding saline
Injecting multi-dose kit vial
4
Nucg
Removing possible airbubbles
Transfer of unshielded
syringe into transport box
Injecting patient together
with saline and use of
butterfly cannula and
3-way valve
16-7-2015
routinedosimetrie




5
Borstdosimetrie
Polsdosimetrie
Ringdosimetrie
Vingertopdosimetrie
Nucg
16-7-2015
6
Nucg
16-7-2015
Routinedosimetrie in de praktijk:
verplegenden
10
9
8
7
6
Pols Verpleging 1
5
Pols Verpleging 2
4
Pols Verpleging 3
3
2
1
0
2002
7
Nucg
2003
2004
2005
2006
2007
2008
16-7-2015
Routinedosimetrie in de praktijk:
radiofarmaceuten
600
500
400
Pols Radiofarmacie 1
Pols Radiofarmacie 2
300
Vinger Radiofarmacie 1
Vinger Radiofarmacie 2
200
100
0
1993
8
Nucg
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
16-7-2015
Radiopharmacist B: Distribution of Monthly Hp(0.07) for 3 manipulations and present Workload
50
Dispensing syringes F-18 FDG
45
Dispensing syringes Tc-99m labelled
radiopharmaceuticals
Kit preparation Tc-99m labelled
radiopharmaceuticals
Average MHp(0.07) ( mSv/ month )
40
35
30
25
20
15
10
5
R01
R02
R03
R04
R05
R06
R07
R08
R09
R10
R11
R12
R13
R14
R15
R16
R17
L18
R18
L17
L16
L15
L14
L13
L12
L11
L10
L09
L08
L07
L06
L05
L04
L03
L02
L01
0
Location
9
Nucg
16-7-2015
Vingerdosimetrie


10
Overschrijding limiet
Procedure
Nucg
16-7-2015
Recente vingerdosimetrie
40
35
30
25
20
15
Radiofarmaceut 1
10
Radiofarmaceut 2
5
0
apr 2008
11
Nucg
jun 2008
jul 2008
sep 2008
okt 2008
dec 2008
feb 2009
mrt 2009
mei 2009
16-7-2015
Tc-99m versus FDG-18


12
Productie
Workload
Nucg
16-7-2015
Radiopharmacist B: Distribution of Monthly Hp(0.07) for 3 manipulations and present Workload
50
Dispensing syringes F-18 FDG
45
Dispensing syringes Tc-99m labelled
radiopharmaceuticals
Kit preparation Tc-99m labelled
radiopharmaceuticals
Average MHp(0.07) ( mSv/ month )
40
35
30
25
20
15
10
5
R01
R02
R03
R04
R05
R06
R07
R08
R09
R10
R11
R12
R13
R14
R15
R16
R17
L18
R18
L17
L16
L15
L14
L13
L12
L11
L10
L09
L08
L07
L06
L05
L04
L03
L02
L01
0
Location
13
Nucg
16-7-2015
En verder



14
Raadplegingen
Besmettingen
Opleiding en opvolging
Nucg
16-7-2015
Besluit




15
Routine evaluatie
Studies
Optimalisatie
Besmettingen
Nucg
16-7-2015